Peak6 Investments LLC Fibrogen Inc Transaction History

Peak6 Investments LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $432,041 - $568,139	-13,265 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $107,086 - $211,232	4,596 Added 53.02%	13,265 $461,000
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $299,774 - $416,632	8,669 New	8,669 $372,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.